UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s assets related to the oncolytic virus ICVB-1042 ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

Orthopedic researchers have developed a promising new nanoparticle hydrogel that can be injected directly into bones weakened by osteoporosis. In a study recently published in the journal Bone ...

UroGen Pharma Ltd. is a biopharmaceutical company ... It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.

Allied Market Research published a report, titled, "Cell Culture Hydrogel Market By Type of Hydrogel (Natural Hydrogels, Synthetic Hydrogels, Hybrid Hydrogels), By Application (Cancer and Stem Cell ...

About UroGen Pharma Ltd. UroGen is a biotech company ... UroGen has developed RTGel® reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the ...